Log in
Enquire now
‌

US Patent 7893075 Compounds modulating c-fms and/or c-kit activity and uses therefor

Patent 7893075 was granted and assigned to Plexxikon Inc. on February, 2011 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
Plexxikon Inc.
Plexxikon Inc.
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7893075
Patent Inventor Names
Ryan Bremer0
Chao Zhang0
Dean R. Artis0
Guoxian Wu0
Hongyao Zhu0
Jiazhong Zhang0
Marika Nespi0
Prabha N. Ibrahim0
Date of Patent
February 22, 2011
Patent Application Number
11986667
Date Filed
November 21, 2007
Patent Citations Received
‌
US Patent 12076322 Compounds and methods for kinase modulation, and indications therefor
0
‌
US Patent 11944647 Articles of manufacture and methods for treatment using adoptive cell therapy
0
Patent Primary Examiner
‌
D. Margaret Seaman
Patent abstract

Compounds active on the receptor protein tyrosine kinases c-kit and/or c-fms are provided herewith. Also provided herewith are compositions useful for treatment of c-kit mediated diseases or conditions and/or c-fms-mediated diseases or conditions, and methods for the use thereof.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7893075 Compounds modulating c-fms and/or c-kit activity and uses therefor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.